Unicycive Therapeutics, Inc.
(NASDAQ: UNCY)
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
6.315
-0.185
(-2.85%)
Range
6.265 - 6.600
(5.35%)
Open
6.570
Previous Close
6.500
Bid Price
1.370
Bid Volume
40
Ask Price
1.430
Ask Volume
10
Volume
227,145
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 01:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
